Gulraiz Chaudry, M.B.,Ch.B.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphatic Abnormalities | 7 | 2020 | 133 | 3.340 |
Why?
|
Vascular Malformations | 14 | 2020 | 454 | 3.000 |
Why?
|
Hemangioma | 5 | 2020 | 738 | 1.580 |
Why?
|
Embolization, Therapeutic | 6 | 2019 | 1392 | 1.220 |
Why?
|
Osteolysis, Essential | 3 | 2019 | 30 | 1.120 |
Why?
|
Veins | 4 | 2018 | 770 | 1.080 |
Why?
|
Sclerotherapy | 5 | 2019 | 175 | 1.080 |
Why?
|
Hemangioma, Capillary | 2 | 2014 | 61 | 0.930 |
Why?
|
Klippel-Trenaunay-Weber Syndrome | 3 | 2019 | 68 | 0.910 |
Why?
|
Magnetic Resonance Angiography | 4 | 2014 | 1443 | 0.890 |
Why?
|
Muscle Neoplasms | 2 | 2014 | 139 | 0.870 |
Why?
|
Hemangioendothelioma, Epithelioid | 2 | 2019 | 54 | 0.820 |
Why?
|
Musculoskeletal Abnormalities | 2 | 2018 | 95 | 0.680 |
Why?
|
Portal Vein | 3 | 2018 | 437 | 0.680 |
Why?
|
Hepatic Artery | 2 | 2018 | 245 | 0.680 |
Why?
|
Arteriovenous Malformations | 2 | 2020 | 396 | 0.670 |
Why?
|
Radiography, Interventional | 6 | 2019 | 1095 | 0.670 |
Why?
|
Hemangioendothelioma | 2 | 2016 | 121 | 0.630 |
Why?
|
Enbucrilate | 1 | 2018 | 31 | 0.630 |
Why?
|
Lymphatic Diseases | 3 | 2018 | 323 | 0.620 |
Why?
|
Ultrasonography | 7 | 2020 | 5984 | 0.610 |
Why?
|
Capillaries | 1 | 2020 | 773 | 0.590 |
Why?
|
Soft Tissue Neoplasms | 2 | 2019 | 1363 | 0.590 |
Why?
|
Arteriovenous Fistula | 2 | 2018 | 315 | 0.580 |
Why?
|
Vena Cava Filters | 2 | 2011 | 253 | 0.570 |
Why?
|
Varicose Veins | 1 | 2018 | 154 | 0.570 |
Why?
|
Nevus | 1 | 2018 | 204 | 0.560 |
Why?
|
Renal Artery | 2 | 2020 | 399 | 0.550 |
Why?
|
Neck | 1 | 2020 | 698 | 0.540 |
Why?
|
Parotid Neoplasms | 1 | 2017 | 155 | 0.540 |
Why?
|
Lipoma | 1 | 2018 | 334 | 0.540 |
Why?
|
Ultrasonography, Interventional | 5 | 2020 | 1486 | 0.540 |
Why?
|
Sarcoma, Kaposi | 2 | 2016 | 370 | 0.530 |
Why?
|
Head | 1 | 2020 | 880 | 0.500 |
Why?
|
Diagnostic Imaging | 4 | 2016 | 3508 | 0.490 |
Why?
|
Endovascular Procedures | 6 | 2019 | 1980 | 0.480 |
Why?
|
Child, Preschool | 30 | 2020 | 41005 | 0.480 |
Why?
|
Growth Disorders | 1 | 2019 | 645 | 0.480 |
Why?
|
Paraganglioma, Extra-Adrenal | 1 | 2014 | 46 | 0.480 |
Why?
|
Pulmonary Embolism | 3 | 2019 | 2375 | 0.460 |
Why?
|
Glomus Tumor | 1 | 2014 | 66 | 0.460 |
Why?
|
Fascia | 1 | 2014 | 135 | 0.450 |
Why?
|
Bleomycin | 1 | 2014 | 512 | 0.450 |
Why?
|
Device Removal | 3 | 2019 | 656 | 0.440 |
Why?
|
Infant | 24 | 2020 | 35134 | 0.430 |
Why?
|
Duodenal Diseases | 1 | 2013 | 102 | 0.420 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2014 | 210 | 0.410 |
Why?
|
Aneurysm, False | 1 | 2014 | 276 | 0.410 |
Why?
|
Liver Diseases | 2 | 2013 | 1253 | 0.400 |
Why?
|
Sclerosing Solutions | 1 | 2011 | 78 | 0.390 |
Why?
|
Vascular Surgical Procedures | 5 | 2020 | 1476 | 0.390 |
Why?
|
Child | 37 | 2022 | 77709 | 0.390 |
Why?
|
Tissue Plasminogen Activator | 1 | 2017 | 1261 | 0.380 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2014 | 692 | 0.360 |
Why?
|
Heparin | 1 | 2017 | 1637 | 0.360 |
Why?
|
Doxycycline | 1 | 2011 | 326 | 0.350 |
Why?
|
Bacteriocins | 1 | 2010 | 90 | 0.350 |
Why?
|
Nephroma, Mesoblastic | 1 | 2009 | 25 | 0.350 |
Why?
|
Biopsy, Needle | 2 | 2020 | 1641 | 0.350 |
Why?
|
Enterococcus faecium | 1 | 2010 | 102 | 0.330 |
Why?
|
Arterial Occlusive Diseases | 3 | 2020 | 793 | 0.330 |
Why?
|
Phlebography | 3 | 2018 | 333 | 0.320 |
Why?
|
Radiography, Thoracic | 3 | 2014 | 1265 | 0.320 |
Why?
|
Thrombolytic Therapy | 1 | 2017 | 2162 | 0.310 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2013 | 1131 | 0.310 |
Why?
|
Fibrinolytic Agents | 1 | 2017 | 2158 | 0.300 |
Why?
|
Syndrome | 8 | 2020 | 3252 | 0.300 |
Why?
|
Lymph Nodes | 3 | 2013 | 3476 | 0.290 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2530 | 0.290 |
Why?
|
Foreign Bodies | 1 | 2011 | 400 | 0.290 |
Why?
|
Head and Neck Neoplasms | 1 | 2020 | 2736 | 0.280 |
Why?
|
Prosthesis Failure | 1 | 2011 | 1206 | 0.260 |
Why?
|
Liver Neoplasms | 2 | 2019 | 4253 | 0.260 |
Why?
|
Anticoagulants | 2 | 2018 | 4600 | 0.260 |
Why?
|
Lymphography | 2 | 2019 | 201 | 0.260 |
Why?
|
Adolescent | 24 | 2020 | 85779 | 0.250 |
Why?
|
Vena Cava, Inferior | 1 | 2008 | 440 | 0.250 |
Why?
|
DNA, Bacterial | 1 | 2010 | 1465 | 0.250 |
Why?
|
Retrospective Studies | 24 | 2020 | 77460 | 0.250 |
Why?
|
Aorta, Abdominal | 3 | 2018 | 646 | 0.250 |
Why?
|
Skin Neoplasms | 2 | 2014 | 5692 | 0.230 |
Why?
|
Tomography, X-Ray Computed | 4 | 2013 | 20130 | 0.230 |
Why?
|
Pancreatic Diseases | 1 | 2006 | 350 | 0.230 |
Why?
|
Thrombosis | 1 | 2017 | 2968 | 0.230 |
Why?
|
Male | 40 | 2020 | 350115 | 0.220 |
Why?
|
Angiography | 3 | 2018 | 1639 | 0.220 |
Why?
|
Abnormalities, Multiple | 3 | 2019 | 1416 | 0.210 |
Why?
|
Bone and Bones | 1 | 2013 | 2576 | 0.210 |
Why?
|
Humans | 57 | 2022 | 744366 | 0.200 |
Why?
|
Radiology, Interventional | 2 | 2020 | 460 | 0.200 |
Why?
|
Aortic Diseases | 2 | 2020 | 743 | 0.200 |
Why?
|
Magnetic Resonance Imaging | 9 | 2020 | 35425 | 0.190 |
Why?
|
Boston | 6 | 2022 | 9312 | 0.190 |
Why?
|
Treatment Outcome | 17 | 2020 | 63107 | 0.190 |
Why?
|
Intestinal Diseases | 1 | 2006 | 530 | 0.190 |
Why?
|
Tissue Expansion Devices | 2 | 2020 | 156 | 0.190 |
Why?
|
Hypertension, Renovascular | 1 | 2020 | 123 | 0.190 |
Why?
|
Female | 36 | 2020 | 380193 | 0.180 |
Why?
|
Granuloma, Pyogenic | 1 | 2020 | 48 | 0.180 |
Why?
|
Renal Artery Obstruction | 1 | 2020 | 248 | 0.170 |
Why?
|
Venous Thrombosis | 1 | 2008 | 1239 | 0.160 |
Why?
|
Diagnosis, Differential | 6 | 2020 | 12961 | 0.160 |
Why?
|
Infant, Newborn | 10 | 2020 | 25628 | 0.150 |
Why?
|
Young Adult | 12 | 2019 | 56429 | 0.150 |
Why?
|
Jejunostomy | 1 | 2017 | 57 | 0.150 |
Why?
|
Foreign-Body Migration | 1 | 2019 | 222 | 0.150 |
Why?
|
Peripheral Vascular Diseases | 2 | 2014 | 550 | 0.150 |
Why?
|
Radiography | 7 | 2014 | 7023 | 0.150 |
Why?
|
Septal Occluder Device | 1 | 2018 | 128 | 0.150 |
Why?
|
Cystic Fibrosis | 1 | 2006 | 1178 | 0.150 |
Why?
|
Anti-Bacterial Agents | 2 | 2018 | 7182 | 0.140 |
Why?
|
Dilatation, Pathologic | 1 | 2018 | 520 | 0.140 |
Why?
|
Parotid Gland | 1 | 2017 | 168 | 0.140 |
Why?
|
Neurofibromin 1 | 1 | 2018 | 196 | 0.140 |
Why?
|
Upper Extremity | 2 | 2019 | 648 | 0.140 |
Why?
|
Abscess | 1 | 2020 | 607 | 0.140 |
Why?
|
Hypertension, Pulmonary | 1 | 2007 | 1534 | 0.140 |
Why?
|
Catheterization, Central Venous | 1 | 2020 | 514 | 0.140 |
Why?
|
Prosthesis Design | 3 | 2018 | 2110 | 0.130 |
Why?
|
Muscular Diseases | 1 | 2020 | 555 | 0.130 |
Why?
|
Fluoroscopy | 2 | 2017 | 924 | 0.130 |
Why?
|
GTP Phosphohydrolases | 1 | 2018 | 508 | 0.130 |
Why?
|
Kidney Function Tests | 1 | 2017 | 683 | 0.130 |
Why?
|
Equipment Failure | 1 | 2017 | 578 | 0.130 |
Why?
|
Gastrostomy | 1 | 2017 | 310 | 0.130 |
Why?
|
Drainage | 1 | 2020 | 1142 | 0.120 |
Why?
|
Lower Extremity | 2 | 2020 | 1158 | 0.120 |
Why?
|
Neurofibromatoses | 1 | 2018 | 299 | 0.120 |
Why?
|
Blood Loss, Surgical | 1 | 2018 | 662 | 0.120 |
Why?
|
Angioplasty, Laser | 1 | 2013 | 21 | 0.120 |
Why?
|
Antibiotic Prophylaxis | 1 | 2018 | 639 | 0.110 |
Why?
|
Aorta | 1 | 2020 | 2062 | 0.110 |
Why?
|
Kidney Neoplasms | 1 | 2009 | 4262 | 0.110 |
Why?
|
Aortic Coarctation | 1 | 2014 | 281 | 0.110 |
Why?
|
Time Factors | 7 | 2020 | 40075 | 0.110 |
Why?
|
Clinical Protocols | 1 | 2018 | 1461 | 0.100 |
Why?
|
Vascular Diseases | 1 | 2020 | 1161 | 0.100 |
Why?
|
Thrombin | 1 | 2014 | 598 | 0.100 |
Why?
|
Muscle, Skeletal | 2 | 2020 | 4925 | 0.100 |
Why?
|
Knee Joint | 2 | 2011 | 1680 | 0.100 |
Why?
|
Skin Diseases | 1 | 2020 | 1066 | 0.100 |
Why?
|
Adult | 13 | 2020 | 214052 | 0.100 |
Why?
|
Endothelial Cells | 2 | 2022 | 3486 | 0.100 |
Why?
|
Chylothorax | 1 | 2011 | 84 | 0.090 |
Why?
|
Respiratory Function Tests | 1 | 2014 | 1617 | 0.090 |
Why?
|
Food Microbiology | 1 | 2010 | 78 | 0.090 |
Why?
|
Surgical Wound Infection | 1 | 2018 | 1540 | 0.080 |
Why?
|
Rare Diseases | 1 | 2014 | 553 | 0.080 |
Why?
|
Risk Factors | 6 | 2020 | 72296 | 0.080 |
Why?
|
Sex Distribution | 1 | 2014 | 2297 | 0.080 |
Why?
|
Sirolimus | 1 | 2016 | 1565 | 0.080 |
Why?
|
Surgical Instruments | 1 | 2011 | 395 | 0.080 |
Why?
|
Incidence | 2 | 2018 | 20952 | 0.080 |
Why?
|
Age Distribution | 1 | 2014 | 2902 | 0.080 |
Why?
|
Lung, Hyperlucent | 1 | 2007 | 5 | 0.080 |
Why?
|
Age Factors | 3 | 2020 | 18373 | 0.070 |
Why?
|
Catheterization | 1 | 2013 | 1470 | 0.070 |
Why?
|
Biopsy | 1 | 2019 | 6755 | 0.070 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2007 | 110 | 0.070 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2010 | 954 | 0.070 |
Why?
|
Dairy Products | 1 | 2010 | 498 | 0.070 |
Why?
|
Bronchial Diseases | 1 | 2007 | 151 | 0.070 |
Why?
|
Polymerase Chain Reaction | 2 | 2018 | 6171 | 0.070 |
Why?
|
Hyperthermia, Induced | 1 | 2009 | 403 | 0.070 |
Why?
|
Hypertension | 2 | 2018 | 8479 | 0.070 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2009 | 459 | 0.070 |
Why?
|
Aortic Valve Stenosis | 1 | 2018 | 1965 | 0.060 |
Why?
|
Joint Diseases | 1 | 2009 | 479 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15078 | 0.060 |
Why?
|
Gene Amplification | 1 | 2010 | 1063 | 0.060 |
Why?
|
Quality Improvement | 1 | 2020 | 3749 | 0.060 |
Why?
|
Sequence Alignment | 1 | 2010 | 2256 | 0.060 |
Why?
|
Surgery, Computer-Assisted | 2 | 2013 | 1018 | 0.060 |
Why?
|
Knee Injuries | 1 | 2009 | 490 | 0.060 |
Why?
|
Pain | 1 | 2020 | 4988 | 0.060 |
Why?
|
Length of Stay | 1 | 2018 | 6311 | 0.060 |
Why?
|
Cardiomegaly | 1 | 2007 | 620 | 0.060 |
Why?
|
Microbial Sensitivity Tests | 1 | 2010 | 1877 | 0.060 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39052 | 0.060 |
Why?
|
Spine | 1 | 2011 | 1144 | 0.060 |
Why?
|
Antihypertensive Agents | 1 | 2013 | 2047 | 0.060 |
Why?
|
Lung | 1 | 2022 | 9857 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2016 | 4153 | 0.050 |
Why?
|
Statistics as Topic | 1 | 2009 | 2373 | 0.050 |
Why?
|
Spinal Cord | 1 | 2011 | 1810 | 0.050 |
Why?
|
Databases, Factual | 1 | 2017 | 7730 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2018 | 7882 | 0.050 |
Why?
|
Mesenteric Arteries | 1 | 2020 | 183 | 0.050 |
Why?
|
Ischemia | 1 | 2009 | 1907 | 0.040 |
Why?
|
Vena Cava, Superior | 1 | 2020 | 193 | 0.040 |
Why?
|
Replantation | 1 | 2020 | 148 | 0.040 |
Why?
|
Intestines | 1 | 2009 | 1924 | 0.040 |
Why?
|
Combined Modality Therapy | 3 | 2019 | 8642 | 0.040 |
Why?
|
Tissue Expansion | 1 | 2020 | 162 | 0.040 |
Why?
|
Iliac Artery | 1 | 2020 | 364 | 0.040 |
Why?
|
Neoplasm Staging | 1 | 2013 | 11031 | 0.040 |
Why?
|
Bone Marrow Transplantation | 1 | 2007 | 2765 | 0.040 |
Why?
|
Suction | 1 | 2020 | 267 | 0.040 |
Why?
|
Image Enhancement | 1 | 2009 | 2921 | 0.040 |
Why?
|
Neovascularization, Pathologic | 1 | 2009 | 2638 | 0.040 |
Why?
|
Influenza, Human | 1 | 2009 | 1479 | 0.040 |
Why?
|
Base Sequence | 1 | 2010 | 12797 | 0.040 |
Why?
|
Dissection | 1 | 2020 | 295 | 0.040 |
Why?
|
Catheters, Indwelling | 1 | 2020 | 426 | 0.040 |
Why?
|
Pulmonary Artery | 1 | 2007 | 1912 | 0.040 |
Why?
|
Contrast Media | 2 | 2011 | 5300 | 0.040 |
Why?
|
Amino Acid Sequence | 1 | 2010 | 13814 | 0.040 |
Why?
|
Mutation | 2 | 2019 | 29786 | 0.040 |
Why?
|
Molecular Sequence Data | 1 | 2010 | 18111 | 0.040 |
Why?
|
Aortography | 1 | 2018 | 437 | 0.030 |
Why?
|
Blood Vessel Prosthesis | 1 | 2020 | 934 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2020 | 2124 | 0.030 |
Why?
|
Graft vs Host Disease | 1 | 2007 | 2958 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 2018 | 987 | 0.030 |
Why?
|
Echocardiography | 1 | 2007 | 5099 | 0.030 |
Why?
|
Graft Rejection | 1 | 2007 | 4397 | 0.030 |
Why?
|
Survival Rate | 2 | 2019 | 12788 | 0.030 |
Why?
|
Ethiodized Oil | 1 | 2011 | 33 | 0.030 |
Why?
|
Enteral Nutrition | 1 | 2017 | 767 | 0.030 |
Why?
|
Disease Progression | 2 | 2019 | 13286 | 0.020 |
Why?
|
Drug Resistance, Bacterial | 1 | 2018 | 1035 | 0.020 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2020 | 1391 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4933 | 0.020 |
Why?
|
Port-Wine Stain | 1 | 2010 | 33 | 0.020 |
Why?
|
Reoperation | 1 | 2020 | 4201 | 0.020 |
Why?
|
Pedigree | 1 | 2018 | 4642 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2007 | 8949 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2013 | 1107 | 0.020 |
Why?
|
Consensus | 1 | 2018 | 2960 | 0.020 |
Why?
|
Algorithms | 1 | 2009 | 13882 | 0.020 |
Why?
|
Facial Asymmetry | 1 | 2010 | 171 | 0.020 |
Why?
|
Gastric Bypass | 1 | 2017 | 812 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2018 | 2703 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8340 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 3914 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4216 | 0.020 |
Why?
|
Aged | 1 | 2019 | 163288 | 0.020 |
Why?
|
Radiographic Image Enhancement | 1 | 2011 | 885 | 0.020 |
Why?
|
Prognosis | 2 | 2019 | 29060 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2009 | 1590 | 0.020 |
Why?
|
Middle Aged | 1 | 2019 | 213390 | 0.020 |
Why?
|
Blood Pressure | 1 | 2020 | 8551 | 0.020 |
Why?
|
Liver | 1 | 2020 | 7475 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2011 | 1257 | 0.010 |
Why?
|
Anesthesia, General | 1 | 2011 | 1171 | 0.010 |
Why?
|
Observer Variation | 1 | 2009 | 2593 | 0.010 |
Why?
|
Genetic Variation | 1 | 2018 | 6542 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3508 | 0.010 |
Why?
|
Cohort Studies | 2 | 2018 | 40559 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6539 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2014 | 3280 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2011 | 5077 | 0.010 |
Why?
|
Pilot Projects | 1 | 2011 | 8319 | 0.010 |
Why?
|
United States | 2 | 2018 | 69872 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15535 | 0.010 |
Why?
|
Quality of Life | 1 | 2016 | 12802 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 14723 | 0.010 |
Why?
|
Risk Assessment | 1 | 2014 | 23336 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2009 | 19905 | 0.010 |
Why?
|
Prospective Studies | 1 | 2016 | 53290 | 0.010 |
Why?
|